Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): SARGENT, ALISON OR;
  2. Responsible officer name: SARGENT, ALISON
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (67)
Results: 1-50 | Export
  1. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Bettina Hamelin, President
    Registration: 110 of 110 (2024-04-08 to present)
    Posted: 2024-04-25
    Subject matter details: 24
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  2. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Bettina Hamelin, President
    Registration: 109 of 110 (2024-04-08 to 2024-04-08)
    Posted: 2024-04-25
    Subject matter details: 24
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: David Renwick, Interim President
    Registration: 108 of 110 (2023-12-11 to 2024-04-08)
    Posted: 2023-12-11
    Subject matter details: 29
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  4. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: David Renwick, Interim President
    Registration: 107 of 110 (2023-11-17 to 2023-12-11)
    Posted: 2023-11-17
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  5. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 106 of 110 (2023-10-23 to 2023-11-17)
    Posted: 2023-10-31
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  6. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 105 of 110 (2023-09-11 to 2023-10-23)
    Posted: 2023-09-14
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  7. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 104 of 110 (2023-06-16 to 2023-09-11)
    Posted: 2023-06-19
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  8. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 103 of 110 (2023-06-09 to 2023-06-16)
    Posted: 2023-06-12
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  9. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 102 of 110 (2023-04-28 to 2023-06-09)
    Posted: 2023-05-05
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  10. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 101 of 110 (2022-12-12 to 2023-04-28)
    Posted: 2022-12-14
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  11. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 100 of 110 (2022-11-07 to 2022-12-12)
    Posted: 2022-11-09
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  12. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 99 of 110 (2022-09-16 to 2022-11-07)
    Posted: 2022-09-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 10
  13. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 98 of 110 (2022-09-07 to 2022-09-16)
    Posted: 2022-09-07
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  14. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 97 of 110 (2022-07-25 to 2022-09-07)
    Posted: 2022-07-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  15. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 96 of 110 (2022-06-08 to 2022-07-25)
    Posted: 2022-06-08
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  16. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 95 of 110 (2022-05-11 to 2022-06-08)
    Posted: 2022-05-11
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  17. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 94 of 110 (2022-03-18 to 2022-05-11)
    Posted: 2022-04-13
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  18. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 93 of 110 (2021-12-14 to 2022-03-18)
    Posted: 2021-12-14
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  19. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 92 of 110 (2021-10-22 to 2021-12-14)
    Posted: 2021-10-22
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  20. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 91 of 110 (2021-10-04 to 2021-10-22)
    Posted: 2021-10-05
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  21. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 90 of 110 (2021-08-26 to 2021-10-04)
    Posted: 2021-08-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  22. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 89 of 110 (2021-07-13 to 2021-08-26)
    Posted: 2021-07-13
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  23. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 88 of 110 (2021-03-01 to 2021-07-13)
    Posted: 2021-03-01
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  24. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 87 of 110 (2021-02-16 to 2021-03-01)
    Posted: 2021-02-16
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  25. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 86 of 110 (2021-01-04 to 2021-02-16)
    Posted: 2021-01-04
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  26. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 85 of 110 (2020-10-26 to 2021-01-04)
    Posted: 2020-10-26
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  27. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 84 of 110 (2020-10-09 to 2020-10-26)
    Posted: 2020-10-09
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  28. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 83 of 110 (2020-09-03 to 2020-10-09)
    Posted: 2020-09-03
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  29. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 82 of 110 (2020-08-10 to 2020-09-03)
    Posted: 2020-08-10
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  30. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 81 of 110 (2020-05-25 to 2020-08-10)
    Posted: 2020-05-25
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  31. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 80 of 110 (2020-03-10 to 2020-05-25)
    Posted: 2020-03-10
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  32. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 79 of 110 (2020-01-08 to 2020-03-10)
    Posted: 2020-01-09
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  33. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 78 of 110 (2019-11-15 to 2020-01-08)
    Posted: 2019-11-15
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  34. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 77 of 110 (2019-09-11 to 2019-11-15)
    Posted: 2019-09-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  35. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 76 of 110 (2019-08-02 to 2019-09-11)
    Posted: 2019-08-02
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  36. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 74 of 110 (2019-07-11 to 2019-07-11)
    Posted: 2019-07-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  37. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 75 of 110 (2019-07-11 to 2019-08-02)
    Posted: 2019-07-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  38. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 73 of 110 (2019-02-12 to 2019-07-11)
    Posted: 2019-02-13
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  39. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 72 of 110 (2019-01-11 to 2019-02-12)
    Posted: 2019-01-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  40. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 71 of 110 (2019-01-03 to 2019-01-11)
    Posted: 2019-01-04
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  41. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 70 of 110 (2018-10-15 to 2019-01-03)
    Posted: 2018-10-15
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 18
  42. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 69 of 110 (2018-08-02 to 2018-10-15)
    Posted: 2018-08-02
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 19
  43. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 68 of 110 (2018-07-20 to 2018-08-02)
    Posted: 2018-07-20
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 18
  44. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 67 of 110 (2018-06-28 to 2018-07-20)
    Posted: 2018-07-03
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  45. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 66 of 110 (2018-06-18 to 2018-06-28)
    Posted: 2018-06-18
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  46. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 65 of 110 (2018-06-15 to 2018-06-18)
    Posted: 2018-06-18
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 15
  47. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 64 of 110 (2018-06-12 to 2018-06-15)
    Posted: 2018-06-12
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  48. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 63 of 110 (2018-05-18 to 2018-06-12)
    Posted: 2018-05-22
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  49. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 62 of 110 (2018-05-15 to 2018-05-18)
    Posted: 2018-05-15
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  50. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 61 of 110 (2018-04-23 to 2018-05-15)
    Posted: 2018-04-23
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
Date Modified: